Literature DB >> 33387624

Getting Chemotherapy Directly to the Liver: The Historical Evolution of Hepatic Artery Chemotherapy.

Roi Anteby1, Nancy E Kemeny2, T Peter Kingham3, Michael I D'Angelica3, Alice C Wei3, Vinod P Balachandran3, Jeffrey A Drebin3, Murray F Brennan3, Leslie H Blumgart3, William R Jarnagin3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33387624      PMCID： PMC8320676          DOI： 10.1016/j.jamcollsurg.2020.11.013

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN： 1072-7515            Impact factor:   6.113


× No keyword cloud information.
  44 in total

1.  THE PHYSIOLOGIC DISPOSITION OF 5-FLUOROURACIL AND 5-FLUORO-2'-DEOXYURIDINE IN MAN.

Authors:  B CLARKSON; A O'CONNOR; L WINSTON; D HUTCHISON
Journal:  Clin Pharmacol Ther       Date:  1964 Sep-Oct       Impact factor: 6.875

2.  CHEMOTHERAPY OF METASTATIC LIVER CANCER BY PROLONGED HEPATIC-ARTERY INFUSION.

Authors:  R D SULLIVAN; J W NORCROSS; E WATKINS
Journal:  N Engl J Med       Date:  1964-02-13       Impact factor: 91.245

3.  Antimetabolite-metabolite combination cancer chemotherapy. Effects of intraarterial methotrexate-intramuscular Citrovorum factor therapy in human cancer.

Authors:  R D SULLIVAN; E MILLER; M P SIKES
Journal:  Cancer       Date:  1959 Nov-Dec       Impact factor: 6.860

4.  Hepatic artery and celiac axis infusion for the treatment of upper abdominal malignant lesions.

Authors:  G W Wirtanen; L C Bernhardt; S Mackman; G Ramirez; A R Curreri; F J Ansfield
Journal:  Ann Surg       Date:  1968-07       Impact factor: 12.969

5.  Robotic hepatic arterial infusion pump placement.

Authors:  Motaz Qadan; Michael I D'Angelica; Nancy E Kemeny; Andrea Cercek; T Peter Kingham
Journal:  HPB (Oxford)       Date:  2017-01-26       Impact factor: 3.647

6.  Continuous regional chemotherapy for metastatic colorectal cancer using a totally implantable infusion pump. A feasibility study in 50 patients.

Authors:  C M Balch; M M Urist; M L McGregor
Journal:  Am J Surg       Date:  1983-02       Impact factor: 2.565

7.  Long-term hepatic arterial infusion chemotherapy. Anatomic considerations, operative technique, and treatment morbidity.

Authors:  J M Daly; N Kemeny; P Oderman; J Botet
Journal:  Arch Surg       Date:  1984-08

Review 8.  Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma.

Authors:  Lucas M Boehm; Thejus T Jayakrishnan; John T Miura; Anthony J Zacharias; Fabian M Johnston; Kiran K Turaga; T Clark Gamblin
Journal:  J Surg Oncol       Date:  2014-09-01       Impact factor: 3.454

9.  Sclerosing cholangitis after continuous hepatic artery infusion of FUDR.

Authors:  M M Kemeny; H Battifora; D W Blayney; G Cecchi; D A Goldberg; L A Leong; K A Margolin; J J Terz
Journal:  Ann Surg       Date:  1985-08       Impact factor: 12.969

10.  Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.

Authors:  F E Buisman; M Y V Homs; D J Grünhagen; W F Filipe; R J Bennink; M G H Besselink; I H M Borel Rinkes; R C G Bruijnen; A Cercek; M I D'Angelica; O M van Delden; M L Donswijk; L van Doorn; P G Doornebosch; J Emmering; J I Erdmann; N S IJzerman; C Grootscholten; J Hagendoorn; N E Kemeny; T P Kingham; E G Klompenhouwer; N F M Kok; S Koolen; K F D Kuhlmann; M C Kuiper; M G E Lam; R H J Mathijssen; A Moelker; E Oomen-de Hoop; C J A Punt; W W Te Riele; J M L Roodhart; R J Swijnenburg; W Prevoo; P J Tanis; M Vermaas; M W J Versleijen; F P Veuger; M J Weterman; C Verhoef; B Groot Koerkamp
Journal:  BMC Cancer       Date:  2019-04-05       Impact factor: 4.430
View more
  1 in total

1.  Analysis of Hepatic Artery Infusion (HAI) Chemotherapy Using Randomized Trials of Floxuridine (FUDR) for Colon Cancer Patients with Multiple Liver Metastases.

Authors:  Yuanming Li
Journal:  Gastroenterol Res Pract       Date:  2022-04-27       Impact factor: 1.919
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.